Bronchiolitis obliterans syndrome after lung transplantation and health- related quality of life

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 6, 2000, Pages 1937-1941

  Van Den Berg, Jan W K ^a   Geertsma, Albert ^a   Van Der Bij, Wim ^a   Koëter, Gerard H ^a   De Boer, Willem J ^a   Postma, Dirkje S ^a   Ten Vergert, Els M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY; ARTICLE; BRONCHIOLITIS; DEPRESSION; EMOTION; FEMALE; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PAIN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SLEEP; SOCIAL INTERACTION; WELLBEING;

EID: 0034047254     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.6.9909092     Document Type: Article

References (30)

1. 1. Hosenpud, J. D., L. E. Bennett, B. M. Keck, B. Fiol, and R. J. Novick. 1997. The Registry of the International Society for Heart and Lung Transplantation: fourteenth official report - 1997. J. Heart Lung Transplant. 16:691-712.
2. 2. Hosenpud, J. D., L. E. Bennett, B. M. Keck, B. Fiol, M. M. Boucek, and R. J. Novick. 1998. The Registry of the International Society for Heart and Lung Transplantation: fifteenth official report - 1998. J. Heart Lung Transplant. 17:656-668.
3. 3. Sharples, L. D., M. Tamm, K. McNeil, T. W. Higenbottam, S. Stewart, and J. Wallwork. 1996. Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation: early risk factors. Transplantation 61:560-566.
4. 4. Burke, C. M., J. Theodore, K. D. Dawkins, S. A. Yousem, N. Blank, M. E. Billingham, A. Van Kessel, S. W. Jamieson, P. E. Oyer, and J. C. Baldwin. 1984. Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest 86:824-829.
5. 5. Girgis, R. E., I. Tu, G. J. Berry, H. Reichenspurner, V. G. Valentine, J. V. Conte, A. Ting, I. Johnstone, J. Miller, R. C. Robbins, B. A. Reitz, and J. Theodore. 1996. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J. Heart Lung Transplant. 15:1200-1208.
6. 6. Valentine, V. G., R. C. Robbins, G. J. Berry, H. R. Patel, H. Reichenspurner, B. A. Reitz, and J. Theodore. 1996. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J. Heart Lung Transplant. 15:371-383.
7. 7. Date, H., J. P. Lynch, S. Sundaresan, G. A. Patterson, and E. P. Trulock. 1998. The impact of cytolytic therapy on bronchiolitis obliterans syndrome. J. Heart Lung Transplant. 17:869-875.
8. 8. Reichenspurner, H., R. E. Girgis, R. C. Robbins, K. L. Yun, M. Nitschke, G. J. Berry, R. E. Morris, J. Theodore, and B. A. Reitz. 1996. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. Ann. Thorac. Surg. 62:1467-1472.
9. 9. TenVergert, E. M., M. L. EssinkBot, A. Geertsma, P. J. vanEnckevort, W. J. deBoer, and W. vander Bij. 1998. The effect of lung transplantation on health-related quality of life: a longitudinal study. Chest 113: 358-364.
10. 10. Hosenpud, J. D., L. E. Bennett, B. M. Keck, E. B. Edwards, and R. J. Novick. 1998. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 351:24-27.
11. 11. Cooper, J. D., M. Billingham, T. Egan, M. I. Hertz, T. Higenbottam, J. Lynch, J. Mauer, I. Paradis, G. A. Patterson, C. Smith, et al. 1993. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts: International Society for Heart and Lung Transplantation. J. Heart Lung Transplant. 12:713-716.
12. 12. Hunt, S. M., J. McEwen, and S. P. McKenna. 1986. Measuring Health Status. Croom Helm, London.
13. 13. Spielberger, C. D., R. L. Gorsuch, and R. E. Lusene. 1970. STA1 Manual for the State-trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto, CA.
14. 14. Zung, W. W., C. J. Richards, and M. J. Short. 1965. Self-rating depression scale in an outpatient clinic: further validation of the SDS. Arch. Gen. Psychiatry 13:508-515.
15. 15. Campbell, A. 1976. Subjective measures of well-being. Am. Psychol. 31: 117-124.
16. 16. Gross, C. R., K. Savik, R. M. Bolman, and M. I. Hertz. 1995. Long-term health status and quality of life outcomes of lung transplant recipients. Chest 108:1587-1593.
17. 17. Caine, N., L. D. Sharples, C. Dennis, T. W. Higenbottam, and J. Wallwork. 1996. Measurement of health-related quality of life before and after heart-lung transplantation. J. Heart Lung Transplant. 15:1047-1058.
18. 18. MacNaughton, K. L., J. R. Rodrigue, M. Cicale, and E. M. Staples. 1998. Health-related quality of life and symptom frequency before and after lung transplantation. Clin. Transplant. 12:320-323.
19. 19. O'Brien, B. J., N. R. Banner, S. Gibson, and M. H. Yacoub. 1988. The Nottingham Health Profile as a measure of quality of life following combined heart and lung transplantation. J. Epidemiol. Community Health 42:232-234.
20. 20. Cohen, L., C. Littlefield, P. Kelly, J. Maurer, and S. Abbey. 1998. Predictors of quality of life and adjustment after lung transplantation. Chest 113:633-644.
21. 21. Ramsey, S. D., D. L. Patrick, S. Lewis, R. K. Albert, and G. Raghu. 1995. Improvement in quality of life after lung transplantation: a preliminary study. The University of Washington Medical Center Lung Transplant Study Group. J. Heart Lung Transplant. 14:870-877.
22. 22. Bando, K., I. L. Paradis, S. Similo, H. Konishi, K. Komatsu, T. G. Zullo, S. A. Yousem, J. M. Close, A. Zeevi, R. J. Duquesnoy, et al. 1995. Obliterative bronchiolitis after lung and heart-lung transplantation: an analysis of risk factors and management. J. Thorac. Cardiovasc. Surg. 110:4-13.
23. 23. Heng, D., L. D. Sharples, K. McNeil, S. Stewart, T. Wreghitt, and J. Wallwork. 1998. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J. Heart Lung Transplant. 17:1255-1263.
24. 24. Husain, A. N., M. T. Siddiqui, E. W. Holmes, A. J. Chandrasekhar, M. McCabe, R. Radvany, and E. R. Garrity. 1999. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am. J. Respir. Crit. Care Med. 159:829-833.
25. 25. Keenan, R. J., M. E. Lega, J. S. Dummer, I. L. Paradis, J. H. Dauber, H. Rabinowich, S. A. Yousem, R. L. Hardesty, B. P. Griffith, and R. J. Duquesnoy. 1991. Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation. Transplantation 51:433-438.
26. 26. Kroshus, T. J., V. R. Kshettry, K. Savik, R. John, M. I. Hertz, and R. M. Bolman. 1997. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J. Thorac. Cardiovasc. Surg. 114:195-202.
27. 27. Snell, G. I., D. S. Esmore, and T. J. Williams. 1996. Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation. Chest 109:874-878.
28. 28. Kesten, S., N. Rajagopalan, and J. Maurer. 1996. Cytolytic therapy for the treatment of bronchiolitis obliterans syndrome following lung transplantation. Transplantation 61:427-430.
29. 29. Kesten, S., C. Chaparro, M. Scavuzzo, and C. Gutierrez. 1997. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome. J. Heart Lung Transplant. 16:905-912.
30. 30. Whyte, R. I., S. J. Rossi, M. S. Mulligan, R. Florn, L. Baker, S. Gupta, F. J. Martinez, and J. P. Lynch. 1997. Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantation. Ann. Thorac. Surg. 64:945-948.